(NASDAQ:AAPL), NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Apple Inc. (“Apple” or the “Company”) (NASDAQ: AAPL) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join This Class Action Lawsuit? Do you, or did […]

(NASDAQ:WOOF), NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Petco Health and Wellness Company, Inc. (“Petco” or the “Company”) (NASDAQ: WOOF) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join This Class Action Lawsuit?

(NasdaqGM:RXST), NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join This Class Action Lawsuit? Do you, or did

(NYSE:FI), NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Fiserv, Inc. (“Fiserv” or the “Company”) (NYSE: FI) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join This Class Action Lawsuit? Do you, or did

(NASDAQ:SRPT), NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Sarepta Therapeutics, Inc. (“Sarepta” or the “Company”) (NASDAQ: SRPT) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join This Class Action Lawsuit? Do you, or

(NYSE:HIMS), NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join This Class Action Lawsuit? Do

(NASDAQ:TEM), NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Tempus AI, Inc. (“Tempus” or the “Company”) (NASDAQ: TEM) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join This Class Action Lawsuit? Do you, or

(NASDAQ:PEPG), NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds PepGen Inc. (“PepGen” or the “Company”) (NASDAQ: PEPG) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join This Class Action Lawsuit? Do you, or did

(NYSE:VSTS), NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Vestis Corporation (“Vestis” or the “Company”) (NYSE: VSTS) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join This Class Action Lawsuit? Do you, or did

(NYSE:IR), Bolt-on acquisition supports the company's growth strategy with compelling opportunities for innovation, market expansion, and long-term value creation within life sciences Demonstrates the company's continued ability to acquire family-owned businesses on a proprietary basis driven by strong relationships and cultivation efforts Investment made at attractive purchase multiple of approximately 9x 2024 Adjusted EBITDA DAVIDSON,